PubMed

Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion.

Porkka K, Khoury HJ, Paquette RL, Matloub Y, Sinha R, Cortes JE.

Cancer. 2009 Nov 18. [Epub ahead of print]PMID: 19924787 [PubMed - as supplied by publisher]Related articles

Development and targeted use of nilotinib in chronic myeloid leukemia.

Fava C, Kantarjian H, Cortes J, Jabbour E.

Drug Des Devel Ther. 2009 Feb 6;2:233-243.PMID: 19920910 [PubMed - as supplied by publisher]Related articles

Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients.

Wu EQ, Johnson S, Beaulieu N, Arana M, Bollu V, Guo A, Coombs J, Feng W, Cortes J.

Curr Med Res Opin. 2009 Nov 11. [Epub ahead of print]PMID: 19905880 [PubMed - as supplied by publisher]Related articles

Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet.

Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, Cervantes F, Deininger M, Gratwohl A, Guilhot F, Hochhaus A, Horowitz M, Hughes T, Kantarjian H, Larson R, Radich J, Simonsson B, Silver RT, Goldman J, Hehlmann R.

J Clin Oncol. 2009 Nov 2. [Epub ahead of print]PMID: 19884523 [PubMed - as supplied by publisher]Related articles

Outcome of patients with FLT3-mutated acute myeloid leukemia in first relapse.

Ravandi F, Kantarjian H, Faderl S, Garcia-Manero G, O'Brien S, Koller C, Pierce S, Brandt M, Kennedy D, Cortes J, Beran M.

Leuk Res. 2009 Oct 28. [Epub ahead of print]PMID: 19878996 [PubMed - as supplied by publisher]Related articles

Clinical Lymphoma & Myeloma . . . and leukemia too!

Cortés JE.

Clin Lymphoma Myeloma. 2009 Oct;9(5):344. No abstract available. PMID: 19858052 [PubMed - in process]Related articlesFree article

Epidemiological study on survival of chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL) patients with BCR-ABL T315I mutation.

Nicolini FE, Mauro MJ, Martinelli G, Kim DW, Soverini S, Muller MC, Hochhaus A, Cortes J, Chuah C, Dufva IH, Apperley JF, Yagasaki F, Pearson JD, Peter S, Sanz Rodriguez C, Preudhomme C, Giles F, Goldman JM, Zhou W.

Blood. 2009 Oct 20. [Epub ahead of print]PMID: 19843886 [PubMed - as supplied by publisher]Related articles

Dynamics and Robustness of Familiarity Memory.

Cortes JM, Greve A, Barrett AB, van Rossum MC.

Neural Comput. 2009 Oct 20. [Epub ahead of print]PMID: 19842985 [PubMed - as supplied by publisher]Related articles

Prognostic and predictive factors and genetic analysis of early breast cancer.

Martín M, González Palacios F, Cortés J, de la Haba J, Schneider J.

Clin Transl Oncol. 2009 Oct;11(10):634-42.PMID: 19828405 [PubMed - in process]Related articles

Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera.

Quintás-Cardama A, Kantarjian H, Manshouri T, Luthra R, Estrov Z, Pierce S, Richie MA, Borthakur G, Konopleva M, Cortes J, Verstovsek S.

J Clin Oncol. 2009 Nov 10;27(32):5418-24. Epub 2009 Oct 13.PMID: 19826111 [PubMed - in process]Related articles

Control of Lipase Enantioselectivity by Engineering the Substrate Binding Site and Access Channel.

Lafaquière V, Barbe S, Puech-Guenot S, Guieysse D, Cortés J, Monsan P, Siméon T, André I, Remaud-Siméon M.

Chembiochem. 2009 Oct 8;10(17):2760-2771. [Epub ahead of print]PMID: 19816890 [PubMed - as supplied by publisher]Related articles

Choosing the best treatment strategy for chronic myeloid leukemia patients resistant to imatinib: weighing the efficacy and safety of individual drugs with BCR-ABL mutations and patient history.

Jabbour E, Hochhaus A, Cortes J, La Rosée P, Kantarjian HM.

Leukemia. 2009 Oct 1. [Epub ahead of print]PMID: 19798095 [PubMed - as supplied by publisher]Related articles

Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalities.

Ravandi F, Issa JP, Garcia-Manero G, O'Brien S, Pierce S, Shan J, Borthakur G, Verstovsek S, Faderl S, Cortes J, Kantarjian H.

Cancer. 2009 Sep 30. [Epub ahead of print]PMID: 19795507 [PubMed - as supplied by publisher]Related articles

Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis.

Tam CS, Kantarjian H, Cortes J, Lynn A, Pierce S, Zhou L, Keating MJ, Thomas DA, Verstovsek S.

J Clin Oncol. 2009 Nov 20;27(33):5587-5593. Epub 2009 Sep 28.PMID: 19786661 [PubMed - as supplied by publisher]Related articles

How to Treat Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Amplified Breast Cancer.

Cortes J, Baselga J.

J Clin Oncol. 2009 Nov 20;27(33):5492-5494. Epub 2009 Sep 28. No abstract available. PMID: 19786653 [PubMed - as supplied by publisher]Related articles

Dasatinib treatment of chronic phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations.

Muller MC, Cortes JE, Kim DW, Druker BJ, Erben P, Pasquini R, Branford S, Hughes TP, Radich JP, Ploughman L, Mukhopadhyay J, Hochhaus A.

Blood. 2009 Sep 24. [Epub ahead of print]PMID: 19779040 [PubMed - as supplied by publisher]Related articles

Second-line therapy and beyond resistance for the treatment of patients with chronic myeloid leukemia post imatinib failure.

Jabbour E, Cortés JE, Kantarjian H.

Clin Lymphoma Myeloma. 2009;9 Suppl 3:S272-9.PMID: 19778852 [PubMed - in process]Related articles

Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era.

Champlin R, de Lima M, Kebriaei P, Rondon G, Fisher T, Jabbour E, Cortés JE, Kantarjian H, Anderlini P, Alousi A, Hosing C, Shpall E, Popat U, Qazilbash M, Andersson B, Giralt S.

Clin Lymphoma Myeloma. 2009;9 Suppl 3:S261-5.PMID: 19778850 [PubMed - in process]Related articles

Riverine input of particulate material and inorganic nutrients to a coastal reef ecosystem at the Caribbean coast of Costa Rica.

Roder C, Cortés J, Jiménez C, Lara R.

Mar Pollut Bull. 2009 Sep 18. [Epub ahead of print] No abstract available. PMID: 19767019 [PubMed - as supplied by publisher]Related articles

Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution.

Santos FP, Faderl S, Garcia-Manero G, Koller C, Beran M, O'Brien S, Pierce S, Freireich EJ, Huang X, Borthakur G, Bueso-Ramos C, de Lima M, Keating M, Cortes J, Kantarjian H, Ravandi F.

Leukemia. 2009 Sep 10. [Epub ahead of print]PMID: 19741728 [PubMed - as supplied by publisher]Related articles

Homoharringtonine, omacetaxine mepesuccinate, and chronic myeloid leukemia circa 2009.

Quintás-Cardama A, Kantarjian H, Cortes J.

Cancer. 2009 Sep 8;115(23):5382-5393. [Epub ahead of print]PMID: 19739234 [PubMed - as supplied by publisher]Related articles

The use of nilotinib or dasatinib after failure to two prior tyrosine kinase inhibitors (TKI): long-term follow-up.

Garg RJ, Kantarjian H, O'Brien S, Quintas-Cardama A, Faderl S, Estrov Z, Cortes J.

Blood. 2009 Sep 3. [Epub ahead of print]PMID: 19729517 [PubMed - as supplied by publisher]Related articles

Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation.

Sever M, Kantarjian H, Pierce S, Jain N, Estrov Z, Cortes J, Verstovsek S.

Int J Hematol. 2009 Aug 29. [Epub ahead of print]PMID: 19728024 [PubMed - as supplied by publisher]Related articles

Triptolide induces cell death independent of cellular responses to imatinib in blast crisis chronic myelogenous leukemia cells including quiescent CD34+ primitive progenitor cells.

Mak DH, Schober WD, Chen W, Konopleva M, Cortes J, Kantarjian HM, Andreeff M, Carter BZ.

Mol Cancer Ther. 2009 Sep;8(9):2509-16. Epub 2009 Sep 1.PMID: 19723894 [PubMed - in process]Related articles

High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses.

Cortes JE, Kantarjian HM, Goldberg SL, Powell BL, Giles FJ, Wetzler M, Akard L, Burke JM, Kerr R, Saleh M, Salvado A, McDougall K, Albitar M, Radich J; Rationale and Insight for Gleevec High-Dose Therapy (RIGHT) Trial Study Group.

J Clin Oncol. 2009 Oct 1;27(28):4754-9. Epub 2009 Aug 31.PMID: 19720924 [PubMed - indexed for MEDLINE]Related articles

Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosis.

Quintás-Cardama A, Kantarjian HM, Manshouri T, Thomas D, Cortes J, Ravandi F, Garcia-Manero G, Ferrajoli A, Bueso-Ramos C, Verstovsek S.

J Clin Oncol. 2009 Oct 1;27(28):4760-6. Epub 2009 Aug 31.PMID: 19720904 [PubMed - indexed for MEDLINE]Related articles

Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: a case report and review of the literature.

Cole S, Kantarjian H, Ault P, Cortés JE.

Clin Lymphoma Myeloma. 2009 Aug;9(4):324-7.PMID: 19717385 [PubMed - in process]Related articles

Expanding our mission: Clinical Lymphoma, Myeloma & Leukemia.

Cheson BD, Cortés JE, Jagannath S.

Clin Lymphoma Myeloma. 2009 Aug;9(4):266. No abstract available. PMID: 19717375 [PubMed - in process]Related articlesFree article

Chronic myeloid leukemia in the tyrosine kinase inhibitor era: what is the best therapy?

Quintás-Cardama A, Cortes J.

Curr Oncol Rep. 2009 Sep;11(5):337-45.PMID: 19679008 [PubMed - in process]Related articles

Omeprazole inhibits IL-4 and IL-13 signaling signal transducer and activator of transcription 6 activation and reduces lung inflammation in murine asthma.

Cortes JR, Rivas MD, Molina-Infante J, Gonzalez-Nuñez MA, Perez-G M, Masa JF, Sanchez JF, Zamorano J.

J Allergy Clin Immunol. 2009 Sep;124(3):607-10, 610.e1. Epub 2009 Aug 8. No abstract available. PMID: 19665777 [PubMed - indexed for MEDLINE]Related articles

A Multinational Study of Health State Preference Values Associated with Chronic Myelogenous Leukemia.

Szabo SM, Levy AR, Davis C, Holyoake TL, Cortes J.

Value Health. 2009 Jul 29. [Epub ahead of print]PMID: 19659707 [PubMed - as supplied by publisher]Related articles

Imatinib and beyond--exploring the full potential of targeted therapy for CML.

Quintás-Cardama A, Kantarjian H, Cortes J.

Nat Rev Clin Oncol. 2009 Sep;6(9):535-43. Epub 2009 Aug 4. Review.PMID: 19652654 [PubMed - indexed for MEDLINE]Related articles

Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase.

Hughes T, Saglio G, Branford S, Soverini S, Kim DW, Müller MC, Martinelli G, Cortes J, Beppu L, Gottardi E, Kim D, Erben P, Shou Y, Haque A, Gallagher N, Radich J, Hochhaus A.

J Clin Oncol. 2009 Sep 1;27(25):4204-10. Epub 2009 Aug 3.PMID: 19652056 [PubMed - indexed for MEDLINE]Related articles

[Colonization by yeasts in newborns and healthcare personnel in a neonatal intensive care unit at a university hospital in Bogotá, Colombia.]

Orozco PA, Cortés JA, Parra CM.

Rev Iberoam Micol. 2009 Jun 30;26(2):108-11. Spanish. PMID: 19631159 [PubMed - indexed for MEDLINE]Related articlesFree article

Optimizing first-line therapy for patients with chronic myeloid leukemia.

Fava C, Cortes J.

Semin Hematol. 2009 Apr;46(2 Suppl 3):S5-10.PMID: 19621543 [PubMed - indexed for MEDLINE]Related articles

Island parity. Puerto Rico needs full payments from federal programs.

Cortes JP.

Mod Healthc. 2009 Jul 6;39(27):21. No abstract available. PMID: 19606669 [PubMed - indexed for MEDLINE]Related articles

Trends in Healthcare Utilization for Diarrhea and Rotavirus Disease in Privately Insured US Children <5 Years of Age, 2001-2006.

Cortes JE, Curns AT, Tate JE, Parashar UD.

Pediatr Infect Dis J. 2009 Jul 9. [Epub ahead of print]PMID: 19590460 [PubMed - as supplied by publisher]Related articles

Azacitidine for the treatment of myelodysplastic syndrome.

Cataldo VD, Cortes J, Quintás-Cardama A.

Expert Rev Anticancer Ther. 2009 Jul;9(7):875-84. Review.PMID: 19589026 [PubMed - indexed for MEDLINE]Related articles

Is ultrasound guidance superior to conventional nerve stimulation for coracoid infraclavicular brachial plexus block?

Taboada M, Rodríguez J, Amor M, Sabaté S, Alvarez J, Cortés J, Atanassoff PG.

Reg Anesth Pain Med. 2009 Jul-Aug;34(4):357-60.PMID: 19574869 [PubMed - indexed for MEDLINE]Related articles

Long-term outcome of patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors after imatinib failure is predicted by the in vitro sensitivity of BCR-ABL kinase domain mutations.

Jabbour E, Jones D, Kantarjian HM, O'Brien S, Tam C, Koller C, Burger JA, Borthakur G, Wierda WG, Cortes J.

Blood. 2009 Sep 3;114(10):2037-43. Epub 2009 Jun 30.PMID: 19567878 [PubMed - indexed for MEDLINE]Related articles

Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R).

Kantarjian H, Pasquini R, Lévy V, Jootar S, Holowiecki J, Hamerschlak N, Hughes T, Bleickardt E, Dejardin D, Cortes J, Shah NP.

Cancer. 2009 Sep 15;115(18):4136-47.PMID: 19536906 [PubMed - indexed for MEDLINE]Related articles

Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial.

Jain N, Reuben JM, Kantarjian H, Li C, Gao H, Lee BN, Cohen EN, Ebarb T, Scheinberg DA, Cortes J.

Cancer. 2009 Sep 1;115(17):3924-34.PMID: 19536894 [PubMed - indexed for MEDLINE]Related articles

Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance.

Verma D, Kantarjian HM, Jones D, Luthra R, Borthakur G, Verstovsek S, Rios MB, Cortes J.

Blood. 2009 Sep 10;114(11):2232-5. Epub 2009 Jun 16.PMID: 19531657 [PubMed - indexed for MEDLINE]Related articles

Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failure.

Quintás-Cardama A, De Souza Santos FP, Kantarjian H, O'Brien S, Faderl S, Awais A, Borthakur G, Cortes J.

Cancer. 2009 Sep 1;115(17):3935-43.PMID: 19517473 [PubMed - indexed for MEDLINE]Related articles

Significance of suboptimal response to imatinib, as defined by the European LeukemiaNet, in the long-term outcome of patients with early chronic myeloid leukemia in chronic phase.

Alvarado Y, Kantarjian H, O'Brien S, Faderl S, Borthakur G, Burger J, Wierda W, Garcia-Manero G, Shan J, Cortes J.

Cancer. 2009 Aug 15;115(16):3709-18.PMID: 19517462 [PubMed - indexed for MEDLINE]Related articles

Inhibition of IGF-IR tyrosine kinase induces apoptosis and cell cycle arrest in imatinib-resistant chronic myeloid leukemia cells.

Shi P, Chandra J, Sun X, Gergely M, Cortes JE, Garcia-Manero G, Arlinghaus RB, Lai R, Amin HM.

J Cell Mol Med. 2009 Jun 5. [Epub ahead of print]PMID: 19508387 [PubMed - as supplied by publisher]Related articles

Predictors of primary imatinib resistance in chronic myelogenous leukemia are distinct from those in secondary imatinib resistance.

Zhang WW, Cortes JE, Yao H, Zhang L, Reddy NG, Jabbour E, Kantarjian HM, Jones D.

J Clin Oncol. 2009 Aug 1;27(22):3642-9. Epub 2009 Jun 8.PMID: 19506164 [PubMed - indexed for MEDLINE]Related articles

Basic oral health goals for Spain 2015/2020.

Bravo M, Cortés J, Casals E, Llena C, Almerich-Silla JM, Cuenca E.

Int Dent J. 2009 Apr;59(2):78-82; quiz 62.PMID: 19489286 [PubMed - indexed for MEDLINE]Related articles

Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial.

Apperley JF, Cortes JE, Kim DW, Roy L, Roboz GJ, Rosti G, Bullorsky EO, Abruzzese E, Hochhaus A, Heim D, de Souza CA, Larson RA, Lipton JH, Khoury HJ, Kim HJ, Sillaber C, Hughes TP, Erben P, Van Tornout J, Stone RM.

J Clin Oncol. 2009 Jul 20;27(21):3472-9. Epub 2009 Jun 1.PMID: 19487385 [PubMed - indexed for MEDLINE]Related articles

Significance of increasing levels of minimal residual disease in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in complete cytogenetic response.

Kantarjian HM, Shan J, Jones D, O'Brien S, Rios MB, Jabbour E, Cortes J.

J Clin Oncol. 2009 Aug 1;27(22):3659-63. Epub 2009 Jun 1.PMID: 19487383 [PubMed - indexed for MEDLINE]Related articles